Delivery Order SPE2DB25D3108-SPE2DB25FPCRP

Award Date 4/17/25
Potential Completion Date 4/18/25
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BRILINTA 90 MG TABLET 60S. The contract has an ultimate completion date of April 24, 2025 and a ceiling value of $2,687.32. The contract is not set aside and is an open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,538.56 contract is for the delivery of BRILINTA 90 MG TABLET 60S, a pharmaceutical product, with a completion date of June 5, 2025. The contract is not set-aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides...
This is a $2,390.40 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4567316336 BRILINTA 90 MG TABLET 60S, with a period of performance running through February 20, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
This is a firm fixed-price delivery order award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,245.14 contract is for the supply of BRILINTA 90 MG TABLET 60S, a cardiovascular medication, with a performance period through March 12, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $5,870.18 firm-fixed-price delivery order is for 4566248727 BRILINTA 90 MG TABLET 60S, a cardiovascular medication. The contract has an ultimate completion date of October 29, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of BRILINTA 90 MG TABLET 60S, a pharmaceutical product. The contract has a ceiling value of $2,945.79 and a period of performance through March 5, 2025. AmerisourceBergen, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a...
This is a $2,951.65 firm-fixed-price delivery order awarded by the Defense Logistics Agency Troop Support Medical (DLA Troop Support Medical) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BRILINTA 90 MG TABLET 60S, a cardiovascular medication. This delivery order is placed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,756.86 firm fixed-price delivery order contract is for the provision of BRILINTA 90 MG TABLET 60S, a cardiovascular medication. The contract has an ultimate completion date of January 2, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BRILINTA 90 MG TABLET 60S, a cardiovascular medication. The contract has a ceiling value of $8,555.39 and a performance period through April 19, 2023. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as the primary vehicle for...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $1,572.60 order is for the supply of BRILINTA 90 MG TABLET 60S, a prescription medication, with a completion date of February 9, 2024. The delivery order was awarded under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp as the prime contractor with DLA. This IDC,...
  • SPE2DB25D3108
    Indefinite Delivery Contract
  • SPE2DB25D3108-SPE2DB25FPCRP
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,905.13, is for the supply of BRILINTA 90 MG TABLET 60S, a prescription medication. The contract has an ultimate completion date of April 18, 2025.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This delivery order is likely part of the broader IDC, enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.

Generated 7/17/25, 2:32 PM